972results about How to "No significant difference" patented technology

The invention relates to a kit for measuring the D-Dimer content by adopting a latex immunonephelometry method. The kit comprises a D-Dimer reagent R1, a D-Dimer reagent R2, a D-Dimer diluent and a D-Dimer calibration product, wherein the D-Dimer reagent R1 comprises a buffering solution, a stabilizing agent (1), coagulant and preservative; the D-Dimer reagent R2 comprises mouse anti-human D-Dimer monoclonal antibody latex enhanced particles, a buffering solution, a stabilizing agent (2) and preservative; the D-Dimer diluent comprises a buffering solution and preservative; and the D-Dimer calibration product is prepared by subpacking and freeze-drying a solution comprising a fibrin degradation product D-Dimer, a buffering solution, a stabilizing agent (3), excipient and preservative. The kit has the advantages of simple and rapid operation, accurate quantification, high sensitivity, strong specificity, low detection cost and strong instrument compatibility and is suitable for being popularized and used in various big-scale and small-scale hospitals.

The invention relates to a kit for determining troponin-T (TNT) content of serum, aims to overcome the deficiencies of the above background technology, and provides a kit for detecting troponin-T by an immunoturbidimetry method, wherein the kit does not require sample dilution, has simple operation, high accuracy and good repeatability, and is suitable for various types of fully automatic biochemical analyzers and special protein instruments. A technical scheme is as below: the kit comprises: A. a reagent R1 containing a buffer solution, a preservative, an accelerating agent, inorganic salts, a surfactant and the balance of purified water; b. a reagent R2 containing a buffer solution, latex microspheres with diameter of 60-150 nm combined with anti-human troponin antibodies and an antiseptic; and c. a reference calibrator containing a buffer solution, a stabilizer, a preservative, a certain amount of recombinant human protein troponin-T pure product determined by concentration requirements and the balance of purified water.

The invention provides a latex-enhanced turbidimetric immunoassay kit for quantitatively detecting adiponectin ADPN. The latex-enhanced turbidimetric immunoassay kit comprises an adiponectin R1 reagent and an adiponectin R2 reagent, wherein the adiponectin R1 reagent comprises a buffer solution A, a protective agent A, a reaction enhancer and a preservative; the adiponectin R2 reagent comprises abuffer solution B, a protective agent B, a preservative and sensitized polystyrene latex particles coated with an anti-human adiponectin antibody; the anti-human adiponectin antibody in the sensitizedpolystyrene latex particle coated with the anti-human adiponectin antibody is connected with the sensitized polystyrene latex particle through a streptavidin-biotin system. The invention also provides a preparation method and an application method of the latex-enhanced turbidimetric immunoassay kit for quantitatively detecting adiponectin ADPN. The kit has the advantages that the kit is convenient, rapid, high in sensitivity and specificity and capable of quantitatively and accurately detecting ADPN; and the kit is strong in instrument compatibility and low in detection cost, and makes up theclinical requirements on ADPN turbidimetric products.

The invention relates to a feed additive, and especially relates to a rabbit feed additive. The rabbit feed additive is composed of medicated leaven, Radish Seed, dried orange peel, Weeping Forsythia, Fructus Aurantii, Radix Codonopsis, Poria cocos, white hyacinth bean, lotus seed, coix seed, Fructus Amomi, Radix Platycodonis, Rhizoma Cimicifugae, Combined Spicebush Root, Radix Scutellariae, Cyrtomium fortunei, Amur Corktree Bark and Semen Plantaginis, wherein the medicated leaven, the Radish Seed, the dried orange peel, the Fructus Aurantii, the white hyacinth bean, the Fructus Amomi and the Combined Spicebush Root are simultaneously used for digestion helping and accumulation removing; the dried orange peel, the Weeping Forsythia, the Poria cocos, the white hyacinth bean, the coix seed, the Fructus Amomi, the Rhizoma Cimicifugae, the Radix Scutellariae, the Cyrtomium fortunei, the Amur Corktree Bark and the Semen Plantaginis are simultaneously used for dampness and heat eliminating; the medicated leaven, the dried orange peel, the Radix Codonopsis, the Poria cocos, the white hyacinth bean, the lotus seed, the coix seed, the Fructus Amomi and the Radix Platycodonis are simultaneously used for spleen invigorating and stomach nourishing; and the Combined Spicebush Root, the Cyrtomium fortunei and the Amur Corktree Bark are simultaneously used for parasite expelling, sterilizing and digestive juice secretion increasing. The interaction of the above eighteen medicines can realize digestion helping, accumulation removing and dampness and heat eliminating to prevent diarrhea, and can also realize spleen invigorating, stomach nourishing and spleen and stomach harmonizing to enhance the gastrointestinal function and improve the human immunity.

The invention relates to a Chinese medicine for treating appendicitis. The Chinese medicine consists of the following medicinal materials in part by weight: 30 to 60 parts of honeysuckle, 3 to 60 parts of mongolian dandelion herb, 3 to 60 parts of bunge corydalis herb, 20 to 50 parts of weeping forsythia, 20 to 40 parts of tree peony bark, 6 to 16 parts of frankincense, 4 to 9 parts of myrrh, 6 to 20 parts of green tangerine peel, 6 to 20 parts of liquoric root, 6 to 20 parts of bitter orange, 6 to 20 parts of costustoot, 6 to 20 parts of red paeony root, 0 to 3 parts of bezoar and 0 to 9 parts of saffron. Experiments prove that the Chinese medicine can treat appendicitis safely and effectively.

The invention relates to a 80mm wear-resistant steel plate with large thickness, high toughness and low alloy, and a manufacturing method thereof. The 80mm wear-resistant steel plate with large thickness, high toughness and low alloy is prepared from the components: 0.18 to 0.20 percent of C, 0.20 to 0.40 percent of Si, 0.90 to 1.20 percent of Mn, less than or equal to 0.012 percent of P, less than or equal to 0.002 percent of S, 0.90 to 1.20 percent of Cr, 0.20 to 0.40 percent of Mo, 0.50 to 0.80 percent of Ni, 0.008 to 0.030 percent of Ti, 0.01 to 0.050 percent of Nb, less than or equal to 0.030 percent of V, 0.0008 to 0.0025 percent of B, 0.02 to 0.06 percent of Alt, less than or equal to 0.0040 percent of N, less than or equal to 0.0002 percent of H, and the balance Fe and inevitable impurities. The manufacturing method comprises the steps of carrying out desulfurization pretreatment on molten iron, smelting in a converter, refining LF and RH, continuously casting, stacking castingblanks for slow-cooling, inspecting the casting blanks, judging the casting blanks, checking the casting blanks, heating the casting blanks, dephosphorizing, rolling, air cooling, carrying out flaw detection, shot blasting, quenching, tempering, straightening, cutting and sampling, spray printing logos, inspecting and storing. The steel plate obtained through the invention has the surface Brinellhardness being larger than 400HB, the core Brinell hardness being larger than 330HB, and the low-temperature impact energy at minus 40 DEG C being larger than or equal to 20J.

The invention relates to a kit for measuring the pepsinogen I/II content of human serum. The kit comprises reagents R1 and R2 and a calibration solution, wherein the reagent R1 is a buffer solution of which the PH value is 7.2 to 8.6, the reagent R2 is an anti-human PGI antibody latex reagent or anti-human PGII antibody latex reagent, and a standard substance is recombinant protein containing quantitative PGI or PGII or natural PGI or PGII extracted from the human serum. The kit is characterized by further comprising a reagent R3, wherein the reagent R3 is used for eliminating chyle and is composed of octyl methoxycinnamate, polyoxypropylene polyoxyethylene propylene glycol ether and polyethylene glycol-sulfate chitosan enzyme. The kit has the advantages of high detection sensitivity and strong anti-chyle interference capability and is suitable for detecting severe chyle.

The invention discloses a traditional Chinese medicine for treating viral influenza. The traditional Chinese medicine is characterized by being prepared from the following medicinal materials in parts by weight: 60 parts of gypsum, 150 parts of houttuynia cordata, 150 parts of platycodon grandiflorum, 60 parts of apricot kernel, 120 parts of chrysanthemum, 150 parts of mulberry leaf, 60 parts of herba schizonepetae, 90 parts of mint, 150 parts of rhizoma phragmitis, 150 parts of fructus forsythia, 90 parts of perilla leaf, 120 parts of rhizoma anemarrhenae, 150 parts of honeysuckle, 90 parts of scutellaria baicalensis, 120 parts of chinese mosla herb, 150 parts of root of kudzu vine, 90 parts of liuyi powder, 150 parts of folium isatidis, 120 parts of shikonin, 150 parts of radix isatidis and 60 parts of liquorice. The clinical test proves that the viral influenza can be safely and effectively treated.

The invention discloses a method for determining the quality of a chromium oxide coating in a chromium electroplated plate. The method comprises the following steps: 1, preparing an electrolyte; 2, preparing a sample, and removing an oil film on the surface of the sample; 3, filling an electrolysis measurement device with the sample, and setting the electrolytic current density of the chromium oxide coating in the chromium electroplated plate to be 25-50[mu]A; 4, measuring the electrolysis time and the oxidation reduction potential to obtain a time and potential relationship curve, terminating the measurement when the potential has a descending trend from ascending, and determining the electrolysis reaction termination time through an inflection point existing in the electrolysis curve; and 5, determining the quality of the chromium oxide coatings of multiple samples by using present methods, determining the electrolysis time of the chromium oxide coatings of the corresponding samples, establishing a chromium oxide coating quality electrolysis process measurement model, and reckoning the quality of the chromium oxide coating by using the electrolysis time. Compared with the prior art, the method disclosed in the invention has the advantages of good precision, no significant difference, and rapid and simple measurement.

The invention relates to a traditional Chinese medicine for treating tinnitus cerebri of syndrome of qi depression transforming into fire. The traditional Chinese medicine is prepared by the following medicines according to the weight ratio: 10 parts of uncinata spikemoss herb, 9 parts of rhizoma atractylodis macrocephalae, 8 parts of juncus roemerianus, 20 parts of jasmine, 8 parts of purple perilla, 8 parts of streptolirion volubile, and 15 parts of fructus lycii. As experiments show, the traditional Chinese medicine provided by the invention can safely and effectively treat tinnitus cerebri of syndrome of qi depression transforming into fire.

The invention discloses a traditional Chinese medicine prescription used for treating heart qi deficiency syndrome type chest stuffiness and cardialgia. The traditional Chinese medicine prescription is characterized by comprising, by weight, 10-15 parts of dragon bone, 20-30 parts of oyster, 10-15 parts of ophiopogon root, 4-6 parts of dried ginger, 20-30 parts of dried rehmannia, 20-30 parts of salvia, 20-30 parts of astragalus, 7-10 parts of goldthread root, 20-30 parts of white peony root, 4-6 parts of licorice root, 7-10 parts of schizandrae, 7-10 parts of arborvitae seed, 20-30 parts of spiny jujube, 9-10 parts of donkey-hide glue, 7-10 parts of ginseng, 15-24 parts of tortoise shell, 7-10 parts of amomum, 10-15 parts of turtle shell, 14-20 parts of poria cocos and 7-10 parts of cassia twig. The traditional Chinese medicine prepared by organically combining the preceding raw materials has the functions of quickening blood and removing meridian obstruction, tonifying qi and warming channels, rectifying qi and eliminating phlegm, harmonizing blood and dredging impediment, supplementing heart qi and the like, and as is shown clinically, the effective rate reaches 88%.

The invention discloses a traditional Chinese medicament for treating goiter with depression of the liver to generate pathogenic fire. The medicament is characterized by being prepared from the following raw materials in parts by weight: 10 parts of radix bupleuri, 10 parts of bighead atractylodes rhizome, 20 parts of poria, 10 parts of Chinese angelica, 10 parts of paeonia suffruticosa, 10 parts of cape jasmine, 30 parts of oyster, 30 parts of selfheal, 15 parts of rhizoma cyperi, 12 parts of radix scrophulariae, 10 parts of thunberg fritillary bulb, 15 parts of tangerine seed, 15 parts of semen litchi, 2 parts of pangolin, 10 parts of cowherb seed, 6 parts of liquorice, 20 parts of fructus forsythiae, and 15 parts of radix ranunculi ternate. The traditional Chinese medicament can be used for effectively treating goiter with depression of the liver to generate pathogenic fire, and is good in treatment effect and high in cure rate.

The invention discloses a Chinese herbal composition and extract used for treating depression and a preparation method and an application thereof. The Chinese herbal composition is composed of bupleurum, Chinese angelica, fried white atractylodes rhizome, honey-fried licorice root, mint and dried ginger, thus a formula is simpler. The preparation method of the Chinese herbal composition comprises the steps of weighing the Chinese herbal medicines in proportion, smashing the Chinese herbal medicines, placing the smashed Chinese herbal medicines into a CO2 extraction kettle, controlling parameters such as pressure, temperature, CO2 flow and extraction time and obtaining the extract. Pharmacodynamic test results show that the extract can obviously reduce dead time in a mouse forced swinging test and a mouse tail suspending test, which proves that the extract disclosed by the invention has obvious anti-depression effect, anti-depression activity reaches up to or is higher than those of anti-depression western medicines which are frequently used in clinical application and the traditional anti-depression Chinese herbal medicine compound Xiaoyao powder. And the extract is prepared by adopting an advanced and non-toxic supercritical CO2 extraction process without pollution or solvent residue, thus safety is better, and the extract disclosed by the invention is an ideal anti-depression medicine.

The invention relates to a traditional Chinese medicine capable of invigorating spleen and supplementing qi and treating gastroptosis. The traditional Chinese medicine is prepared from the following medicinal materials in proportion by weight: 20 of rhizoma cimicifugae, 30 of radix astragali, 20 of radix codonopsis, 15 of bighead atractylodes rhizome, 20 of yam, 15 of poria cocos, 15 of angelica sinensis, 15 of radix burpleuri, 15 of radix cureumae, 30 of carapax trionycis, 15 of fructus aurantii immaturus, 5 of radix polygni multiflori, 12 of cornus officinalis, 10 of barbary wolfberry fruit, 8 of American ginseng, 8 of Chinese data, 10 of elecampane, 20 of cuttlebone and 20 of corydalis yanhusuo. Proved by experiment, the traditional Chinese medicine can be used for safely and effectively treating gastroptosis.

The invention relates to a traditional Chinese medicine for clearing lung and eliminating phlegm. The traditional Chinese medicine is prepared from following medicinal materials in parts by weight: 4 parts of papilionaceae eriosema, 5 parts of bryozoatum, 2 parts of hempleaf negundo chastetree leaves, 3 parts of mountain ash, 0.6 part of herba lespedezae cuneatae, 9 parts of fritillaria thun-bergli, 1 part of ardisia japonica, 2 parts of ovate tylophora root and rhizome, 4 parts of asiatic cudweeds, 1 part of adenophora trachelioides maxim, 3 parts of affine cudweeds, 5 parts of sorbus tianchanica, 3 parts of dioscorea nipponica makino, 6 parts of broad-leaved epiphyllum, 3 parts of siberian alder barks, 4 parts of ajuga decumbens thunb, 1 part of rumex crispus, 1.5 parts of cynoglossum amabile stapf et drum, 4 parts of argyreia acuta, 5 parts of gutzlaffia aprica hance, 3 parts of amygdalus mongolica, 1 part of gallusgallusdomesticus brisson, 7 parts of hupeh fritillary bulb, 1 part of apios Americana, 20 parts of paulownia fortunei flowers and 26 parts of peristrophe japonica. A clinical experiment shows that the traditional Chinese medicine can be used for safely and effectively clearing the lung and eliminating the phlegm.

The invention discloses a traditional Chinese medicine for treating liver depression and blood stasis syndrome type breast nodule diseases. The traditional Chinese medicine for treating the liver depression and blood stasis syndrome type breast nodule diseases is characterized by being prepared from the following medicinal materials in parts by weight: 10 parts of Chinese thorowax root, 20 parts of rhizoma atractylodis macrocephalae, 30 parts of Indian Buead, 10 parts of Chinese angelica, 30 parts of white paeony root, 10 parts of peach kernel, 10 parts of rheum officinale, 30 parts of leonurus, 20 parts of rhizoma cyperi, 30 parts of semen coicis, 30 parts of selfheal, 12 parts of scrophularia ningpoensis, 15 parts of keel, 30 parts of oyster, 15 parts of tangerine seed, 15 parts of lychee seed, 6 parts of cowherb seed, 6 parts of liquorice, 10 parts of stir-fried gardenia and 2 parts of pangolin. The traditional Chinese medicine prepared according to the formula has the effects of soothing liver, relieving depression, removing blood stasis, reducing phlegm, softening hard lumps, dispelling nodes and regulating thoroughfare and conception vessels, can effectively treat breast nodule diseases, can also obviously improve the concomitant symptoms of a patient, does not have obvious side effect, and is safe and effective in treatment of the breast nodule diseases. The use of the traditional Chinese medicine on 82 patients in the past three years shows that the effective rate reaches 90.2% and the diseases cannot be relapsed after being cured.

The present invention provides a Chinese medicine composition for treating dementia. The Chinese medicine composition is composed of chuangxiong rhizome extract and gastrodia elata extract. The weight proportion of crude drug is 4:1. The preparing method provided by the invention adopts a resin technique in modern technique of Chinese medicine. A large quantity of impurities are removed and the content of active component is higher. The invention also provides a pharmaceutical preparation of the Chinese medicinal composition and the application in preparing medicine for preparing various dementia symptoms.